SPECC1L and colorectal carcinoma: However, analyses of an independent data set at MD Anderson Cancer Center with stage I–IV CRC samples [19] did not demonstrate a significant correlation between high CYTSA expression and poor clinical outcomes (Supplementary Figure S7A).